Sparks, JonDavid
Eli Lilly (United States)
3 papers on CoChat
Most cited papers
- Verified · note
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
Sims, J. R., Zimmer, J. A., Evans, C. D., Lu, M., Ardayfio, P., Sparks, J., Wessels, A. M., Shcherbinin, S., Wang, H., Monkul Nery, E. S., et al. (2023) · JAMA
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,932
- Verified
Donanemab in Early Alzheimer’s Disease
Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1,728
- Verified
Change blindness, aging, and cognition
Rizzo, M., Sparks, J., McEvoy, S., Viamonte, S., Kellison, I., & Vecera, S. P. (2009) · Journal of Clinical and Experimental Neuropsychology
Visual perception and processing mechanismsVisual Attention and Saliency Detection
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free